News & Events

• March 18, 2021
  

  Welcome Dr. Martijn Muller as CPP Senior Scientific Director

  C-Path is pleased to welcome Martijn Muller, PhD, as Senior Scientific Director for the Critical Path for Parkinson Consortium. Prior to joining C-Path, Martijn was Research Associate Professor of Radiology and Co-Director of the Clinical and Neuroimaging Resource Cores of the Udall Center of Excellence for Parkinson’s disease Research at the University of Michigan. Dr. Muller has a diverse research background with an established publication record in neuropsychology, biomechanics, and neuroimaging.

• September 30, 2019
  

  The Critical Path for Parkinson’s Consortium (CPP) welcomes PMD Alliance as newest member

  The Critical Path for Parkinson’s Consortium (CPP) is thrilled to welcome the PMD Alliance (Parkinson & Movement Disorder Alliance) as our newest member. The PMD Alliance is an independent, national nonprofit organization that provides opportunities for people impacted by Parkinson’s and other movement disorders to learn, live life more fully, and connect with others. Their...
• August 12, 2019
  

  C-Path’s Critical Path for Parkinson’s Consortium (CPP) is pleased to welcome Linda L. Restifo, MD, PhD, as a Visiting Scientist

  C-Path’s Critical Path for Parkinson’s Consortium (CPP) is pleased to welcome Linda L. Restifo, MD, PhD, as a Visiting Scientist. Currently a Professor of Neurology at the University of Arizona College of Medicine – Tucson, Dr. Restifo is a neurogeneticist with broad interests in translational medicine. She will be using her expertise to help CPP...
• June 19, 2019
  

  The Critical Path for Parkinson’s consortium announces C-Path’s Data Sharing Pioneer Award recipients

  The Critical Path for Parkinson’s consortium (CPP) is pleased to announce the following recipients as the first to receive C-Path’s Data Sharing Pioneer Award. This award is bestowed to member organizations and advisors who have demonstrated dedicated commitment to sharing patient-level data for inclusion in our integrated Parkinson’s database. The database is fundamental to CPP’s...
• July 26, 2018
  

  First-ever biomarker qualified for Parkinson’s is a vital step toward improved clinical trials

  FOR IMMEDIATE RELEASE Contact: Kissy Black 615.298.1144 kissyblack@lotosnile.com   Tucson, AZ — July 26, 2018 – The Critical Path Institute’s (C-Path) Critical Path for Parkinson’s Consortium (CPP), in partnership with Parkinson’s UK, announces that the European Medicines Agency (EMA) has issued a positive qualification opinion on an imaging test (biomarker) as a tool to enrich...